---
title: "药明生物(ADR) (WXXWY.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/WXXWY.US/norm.md"
symbol: "WXXWY.US"
name: "药明生物(ADR)"
parent: "https://longbridge.com/zh-CN/quote/WXXWY.US.md"
datetime: "2026-05-20T00:38:22.542Z"
locales:
  - [en](https://longbridge.com/en/quote/WXXWY.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/WXXWY.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/WXXWY.US/norm.md)
---

# 药明生物(ADR) (WXXWY.US) — 财务报表

## 利润表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | 0.0871 | 0.0856 | 0.0769 | 0.0760 | 0.0599 |
| ROE | 10.87% | 11.15% | 10.41% | 10.78% | 8.88% |
| 营业收入 | 845.97M | 831.31M | 693.89M | 685.12M | 691.93M |
| 净利润 | 183.61M | 180.43M | 163.08M | 161.02M | 127.20M |
| 营业利润 | 280.32M | 275.46M | 189.92M | 187.52M | 189.46M |
| 毛利率 | 48.71% | 48.71% | 42.73% | 42.73% | 42.58% |
| 净利率 | 21.70% | 21.70% | 23.50% | 23.50% | 18.38% |
| 利润含金量 | 86.50% | 86.50% | 150.78% | 150.78% | 70.64% |

## 资产负债表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 9.10B | 8.95B | 8.43B | 8.32B | 7.81B |
| 权益乘数 | 1.20 | 1.20 | 1.23 | 1.23 | 1.25 |
| 每股净资产 | 3.27 | 3.21 | 3.08 | 3.04 | 2.79 |
| 资产周转率 | 0.3611 | 0.3468 | 0.3442 | 0.3323 | 0.3289 |
| 现金及短投 | 2.25B | 2.21B | 1.75B | 1.73B | 1.47B |
| 存货与应收 | 197.44M | 194.01M | 230.76M | 227.85M | 208.47M |
| 长期投资 | 4.25B | 4.18B | 4.21B | 4.15B | 3.90B |
| 净债务 | -1.81B | -1.77B | -1.04B | -1.02B | -790.48M |

## 现金流量表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | 324.05M | 318.44M | 125.96M | 124.37M | 268.19M |
| 投资现金流 | -182.17M | -179.01M | -37.52M | -37.05M | -243.80M |
| 融资现金流 | -77.07M | -75.74M | -75.68M | -74.72M | -87.31M |
| 自由现金流 | 124.16M | 269.88M | 78.47M | 140.51M | 56.82M |
| 现金流充裕率 | 121.68% | 121.68% | 63.17% | 63.17% | 160.15% |
| 举债与偿债 | 11.45M | 11.25M | 67.05M | 66.20M | 52.19M |
| 资本支出 | -127.55M | -125.34M | -132.49M | -130.81M | -141.26M |